DrugPatentWatch Database Preview
Drugs in Development Information for L-Alanine
» See Plans and Pricing
What is the development status for investigational drug L-Alanine?
L-Alanine is an investigational drug.
There have been 8 clinical trials for L-Alanine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Myocardial Ischemia, Coronary Disease, and Coronary Artery Disease. The leading clinical trial sponsors are University of Arkansas, Emory University, and Targeted Medical Pharma.
There are one hundred and twenty-six US patents protecting this investigational drug and one international patent.
Summary for L-Alanine
| US Patents | 126 |
| International Patents | 1,488 |
| US Patent Applications | 118 |
| WIPO Patent Applications | 2,513 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2013-11-01) |
| Vendors | 93 |
Recent Clinical Trials for L-Alanine
| Title | Sponsor | Phase |
|---|---|---|
| Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19 | National Cancer Institute (NCI) | Phase 2 |
| Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19 | University of Southern California | Phase 2 |
| Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis | Yonsei University | N/A |
Clinical Trial Summary for L-Alanine
Top disease conditions for L-Alanine
Top clinical trial sponsors for L-Alanine
US Patents for L-Alanine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| L-Alanine | Start Trial | Synthetic polymeric drugs | Ceskoslovenska Akademie Ved (Praha, CS) Carlton Medical Products Limited (London, GB2) | Start Trial |
| L-Alanine | Start Trial | Substituted amino acid compounds | Adir et Compagnie (Courbevoie, FR) | Start Trial |
| L-Alanine | Start Trial | Cyclic anticoagulant peptides | Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) | Start Trial |
| L-Alanine | Start Trial | Amino nitrile intermediate for the preparation of alanine diacetic acid | The Dow Chemical Company (Midland, MI) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for L-Alanine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| L-Alanine | Austria | AT60991 | 2005-01-04 | Start Trial |
| L-Alanine | Australia | AU5183386 | 2005-01-04 | Start Trial |
| L-Alanine | Australia | AU589587 | 2005-01-04 | Start Trial |
| L-Alanine | Canada | CA1305053 | 2005-01-04 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
